IgG4-related ophthalmic disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:449563H05.1
Who is this for?
Show terms as
20Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

IgG4-related ophthalmic disease (also called IgG4-related orbital disease or IgG4-related eye disease) is a condition where the immune system causes chronic inflammation in and around the eyes. It is part of a broader group of conditions known as IgG4-related disease (IgG4-RD), which can affect many organs in the body. In this form, the disease specifically targets the tissues around the eye, including the tear glands (lacrimal glands), the eye muscles, the fat and connective tissue within the eye socket (orbit), and sometimes the eyelids. Patients typically notice painless swelling around one or both eyes, which may cause the eyes to appear puffy or bulging. The tear glands are commonly enlarged, which can lead to dry eyes or excessive tearing. Some people experience double vision if the eye muscles become involved, and in more severe cases, vision can be affected if swollen tissue presses on the optic nerve. The swelling tends to develop slowly over weeks to months. IgG4-related ophthalmic disease is not a cancer, but it can mimic tumors on imaging scans, which is why a biopsy is usually needed for diagnosis. The hallmark finding under the microscope is a dense infiltration of IgG4-positive plasma cells along with a characteristic pattern of fibrosis (scarring). Blood tests often show elevated levels of IgG4 antibodies, though not always. Treatment typically involves corticosteroids (such as prednisone), which usually produce a good initial response. For patients who relapse or cannot tolerate steroids, other immunosuppressive medications or the targeted drug rituximab may be used. Early diagnosis and treatment are important to prevent permanent scarring and damage to the eye structures.

Key symptoms:

Painless swelling around one or both eyesPuffy or swollen eyelidsBulging of the eye (proptosis)Enlarged tear glandsDry eyesExcessive tearingDouble visionBlurred visionFeeling of pressure behind the eyeRestricted eye movementRedness of the eye or eyelidGradual vision loss if the optic nerve is compressedFirm, painless mass in the eye socket area

Clinical phenotype terms (42)— hover any for plain English
Abnormality of the orbital regionHP:0000315DacryocystitisHP:0000620Enlarged lacrimal glandsHP:0007734Abnormal fifth cranial nerve morphologyHP:0010824Abnormal lacrimal gland morphologyHP:0011482AllergyHP:0012393SialadenitisHP:0031281Increased circulating IgG4 levelHP:0032300Periorbital edemaHP:0100539Abnormality of infra-orbital nerveHP:3000061
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for IgG4-related ophthalmic disease.

View clinical trials →

No actively recruiting trials found for IgG4-related ophthalmic disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the IgG4-related ophthalmic disease community →

Specialists

20 foundView all specialists →
ML
Ming Lin
Specialist
2 IgG4-related ophthalmic disease publications
KY
Kazunori Yamada
Specialist
2 IgG4-related ophthalmic disease publications
AA
Atsushi Azumi
Specialist
2 IgG4-related ophthalmic disease publications
SH
Shoko Hamaoka
Specialist
2 IgG4-related ophthalmic disease publications
YX
Yue Xing
DUBLIN, CA
Specialist
2 IgG4-related ophthalmic disease publications
KS
Kazuhisa Sugiyama
Specialist
2 IgG4-related ophthalmic disease publications
TO
Tetsuhiko Okuda
Specialist
2 IgG4-related ophthalmic disease publications
MT
Masayuki Takahira
Specialist
4 IgG4-related ophthalmic disease publications
HG
Hiroshi Goto
KANSAS CITY, KS
Specialist
2 IgG4-related ophthalmic disease publications
ZL
Zhanguo Li
Specialist
PI on 7 active trials819 IgG4-related ophthalmic disease publications
AM
Arezou Khosroshahi, MD
ATLANTA, GA
Specialist
PI on 1 active trial1 IgG4-related ophthalmic disease publication
JD
Jaap M van Laar, Prof. dr.
Specialist
PI on 1 active trial
BM
Brian P Brooks, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 8 active trials
YP
Yair Levy, Prof.
EAST BRUNSWICK, NJ
Specialist
PI on 1 active trial
WC
Wah Cheuk
Specialist
1 IgG4-related ophthalmic disease publication
YL
Yael Lustig
Specialist
1 IgG4-related ophthalmic disease publication
AK
Angie Kwok
STATEN ISLAND, NY
Specialist
1 IgG4-related ophthalmic disease publication
KL
Kenneth Ka Hei Lai
ORLANDO, FL
Specialist
1 IgG4-related ophthalmic disease publication
TA
Terence Wee Xiang Ang
Specialist
1 IgG4-related ophthalmic disease publication
DS
Dinesh Selva
Specialist
1 IgG4-related ophthalmic disease publication

Treatment Centers

8 centers
⚗️ Trial Site

National Institutes of Health Clinical Center

📍 Bethesda, Maryland

👤 Payal P Khincha, M.D.

👤 Christopher Grunseich, M.D.

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

Travel Grants

No travel grants are currently matched to IgG4-related ophthalmic disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open IgG4-related ophthalmic diseaseForum →

No community posts yet. Be the first to share your experience with IgG4-related ophthalmic disease.

Start the conversation →

Latest news about IgG4-related ophthalmic disease

Disease timeline:

New trial: National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - E

Phase NA trial recruiting.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How certain is the diagnosis, and do I need a biopsy to confirm it?,Are any other organs affected by IgG4-related disease, and how will you check for that?,What treatment do you recommend first, and what are the side effects I should watch for?,How long will I need to take steroids, and what is the plan for tapering them?,What are the chances my disease will come back after treatment, and how will we monitor for relapse?,Is rituximab an option for me if steroids alone are not enough?,Could this disease permanently affect my vision, and what can we do to prevent that?

Common questions about IgG4-related ophthalmic disease

What is IgG4-related ophthalmic disease?

IgG4-related ophthalmic disease (also called IgG4-related orbital disease or IgG4-related eye disease) is a condition where the immune system causes chronic inflammation in and around the eyes. It is part of a broader group of conditions known as IgG4-related disease (IgG4-RD), which can affect many organs in the body. In this form, the disease specifically targets the tissues around the eye, including the tear glands (lacrimal glands), the eye muscles, the fat and connective tissue within the eye socket (orbit), and sometimes the eyelids. Patients typically notice painless swelling around on

How is IgG4-related ophthalmic disease inherited?

IgG4-related ophthalmic disease follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does IgG4-related ophthalmic disease typically begin?

Typical onset of IgG4-related ophthalmic disease is adult. Age of onset can vary across affected individuals.

Which specialists treat IgG4-related ophthalmic disease?

20 specialists and care centers treating IgG4-related ophthalmic disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.